Clinical Trial Update: A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and effect of FE 204205 in patients with portal hypertension was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Portal Hypertension

Drugs mentioned

• FE 204205

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Portal Hypertension | Phase 1 | Status: TERMINATED | Results posted: 2019-07-12